Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against <i>Mycobacterium tuberculosis</i> Infection-Reference-Cited by-同舟云学术

Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection

Published:2023 Issue:2 Volume:23 Page:
ISSN:1598-2629
Container-title:Immune Network
language:en
Short-container-title:Immune Netw

Author:

Kwon Kee Woong¹^ORCID,Kang Tae Gun²³^ORCID,Lee Ara²³,Jin Seung Mo⁴,Lim Yong Taik⁴,Shin Sung Jae¹⁵^ORCID,Ha Sang-Jun²³^ORCID

Affiliation:

1. Department of Microbiology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Korea.

2. Department of Biochemistry, College of Life Science & Biotechnology, Yonsei University, Seoul 03722, Korea.

3. Brain Korea 21 (BK21) FOUR Program, Yonsei Education & Research Center for Biosystems, Yonsei University, Seoul 03722, Korea.

4. SKKU Advanced Institute of Nanotechnology (SAINT), Department of Nano Engineering, School of Chemical Engineering, Sungkyunkwan University (SKKU), Suwon 16419, Korea.

5. Institute for Immunology and Immunological Disease, Yonsei University College of Medicine, Seoul 03722, Korea.

Funder

Korea Health Industry Development Institute

Yonsei University

Publisher

XMLink

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

https://immunenetwork.org/pdf/10.4110/in.2023.23.e16

Reference57 articles.

1. The global prevalence of latent tuberculosis: a systematic review and meta-analysis